The national law firm of Parker Waichman LLP has filed a lawsuit in the U.S. District Court for the Western District of Louisiana where joins all other federally filed Actos lawsuits in a multidistrict litigation or MDL under U.S. District Judge Rebecca Doherty.
This lawsuit was filed on behalf of a Louisiana man who developed bladder cancer in 2009 after taking the type 2 diabetes drug Actos from 2007 to 2011. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co. as defendants.
The lawsuit claims severe mental and physical pain and suffering, past and future permanent injuries and emotional distress, economic loss due to medical expenses and living expenses as the result of a new lifestyle. The plaintiff alleges in the complaint that he would not have suffered these effects if the defendants had not concealed the serious risks of the drug Actos, including that using the drug for a year or more significantly increased the risk of bladder cancer. In June, the FDA announced that a 10-year study by Kaiser Permanente found that the risk of bladder cancer increased by 40 percent after one year of Actos use.